Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ: OPRX )

44.30 USD +1.00 (+2.30%)
Streaming Delayed Price Updated: 11:28 AM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 Next >
OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
From GlobeNewswire News Releases
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share
From GlobeNewswire News Releases
OptimizeRx’s Angelo Campano Named to MM+M 40 Under 40 List
List Celebrates Accomplished Young Talent in Medical Marketing 
From GlobeNewswire News Releases
OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ET
From GlobeNewswire News Releases
OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021
From GlobeNewswire News Releases
OptimizeRx Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
OptimizeRx Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
OptimizeRx Expects Q4 2020 Revenue up 117% to Record $16 Million, Full Year up 75% to Record $43 Million
From GlobeNewswire News Releases
OptimizeRx to Present at the B. Riley Securities 2021 Vision Day Virtual Conference on January 28, 2021
From GlobeNewswire News Releases
OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
From GlobeNewswire News Releases
OptimizeRx’s TelaRep™ Recognized as One of the Most Innovative Products for Life Sciences by PM360
TelaRep Helps Replace Lost In-Person Interactions Between Life Sciences and Providers 
From GlobeNewswire News Releases
OptimizeRx CEO, William Febbo, to Speak at Bank of America 4th Annual HCIT and Digital Health Symposium Today, December 9, 2020
From GlobeNewswire News Releases
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
Komodo’s Extensive Healthcare Map Powers Precise Care Milestone Mapping, Improving Support for Providers and Patients 
From GlobeNewswire News Releases
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
For the First Time, Real-World Data is Used to Deliver Real-Time Care Support Information at the Point-Of-Care 
From GlobeNewswire News Releases
OptimizeRx Ranked Number 432 Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500™
Attributes 217% Revenue Growth to Rapidly Expanding Digital Health Platform 
From GlobeNewswire News Releases
OptimizeRx and Questex’s Fierce Life Sciences Tackle Industry’s Top Challenges in Design Thinking Event, Innovate4Outcomes
Event Brings Providers and Life Sciences Leaders Together to Collaborate on Solutions for Better Patient Outcomes 
From GlobeNewswire News Releases
Point-of-Care Industry Expert, Angelo Campano, Joins OptimizeRx Executive Leadership as Senior Vice President and Principal of Agency Channels
Campano Brings More than 15 Years of Experience Leading Digital Channel Partnerships and Innovation 
From GlobeNewswire News Releases
OptimizeRx Third Quarter 2020 Revenue Up 110% to Record $10.5 Million, Driving Non-GAAP Net Income of $1.1 million or $0.07 Per Share
From GlobeNewswire News Releases
OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4:30 p.m. ET
From GlobeNewswire News Releases
OptimizeRx to Participate at Investor Conferences in November
From GlobeNewswire News Releases
OptimizeRx Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating OptimizeRx Corporation for Potential Breaches of Fiduciary Duty By Its Board of Directors
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of... 
From PR Newswire
OptimizeRx Continues Webinar Series, Introducing Innovative Ideas for Transforming New Medication Launches
Presented in Collaboration with the Digital Health Coalition and Diligent Health Solutions 
From GlobeNewswire News Releases
OptimizeRx Expands Direct-to-Patient Reach, Partnering with Epion Health to Provide Adherence and Affordability Support at Point-of-Care
From GlobeNewswire News Releases
OptimizeRx to Participate at Investor Conferences in September
From GlobeNewswire News Releases
OptimizeRx to Present at the LD 500 Virtual Investor Conference on Sept. 3, 2020
From ACCESSWIRE
OptimizeRx Enters Retail Pharmacies, Supporting Adherence by Bringing Prescription Savings Directly to Patients via Higi Smart Health Stations
Healthcare Consumers Will Gain Access to Financial Assistance and Treatment Support Programs from OptimizeRx at Point-of-Dispense 
From GlobeNewswire News Releases
OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second Half
From GlobeNewswire News Releases
OptimizeRx Joins with Change Healthcare to Expand Nationwide Platform Reach
Change Healthcare Users Gain Access to Prescription Savings and Critical Treatment Information Directly at the Point-of-Care 
From GlobeNewswire News Releases
OptimizeRx Sets Second Quarter 2020 Conference Call for Wednesday, August 5, 2020 at 4:30 p.m. ET
From GlobeNewswire News Releases
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.